Avène, officially known as Eau Thermale Avène, is a French dermo-cosmetic and dermatological skincare brand owned by Laboratoires Pierre Fabre. The brand is primarily recognized for products formulated around Avène Thermal Spring Water, targeting sensitive, reactive, dry, and dermatologically compromised skin. Avène integrates the traditions of French thermal-water therapy with modern dermatological research and pharmacy-based skincare practices.

The reported revenue figure of €1.2 billion for 2025 follows Pierre Fabre’s announcement that Avène became its first €1-billion brand in 2023.

Avène functions as a French pharmacy skincare brand centered on dermatology and sensitive skin management. Unlike conventional cosmetics brands that often focus on fragrance or fashion, Avène positions itself within the medical and dermatological sphere of skincare. Its stated areas of expertise include:

• Sensitive and reactive skin
• Damaged or irritated skin
• Very dry and atopy-prone skin
• Acne-prone skin
• Sun protection
• Redness
• Skin aging
• Post-treatment and skin-repair care

Pierre Fabre describes the brand as being “inspired by medical skincare,” leveraging insights from dermatologists, scientists, and its thermal-medicine center. This places Avène in a distinct category between pharmacy skincare, clinical dermatology, and consumer cosmetics.

The history of the brand is rooted in the Avène-les-Bains thermal spring in southern France, which predates the commercial entity by centuries. In 1975, Laboratoires Pierre Fabre acquired the Avène spring and thermal spa.1 Following this acquisition, the company invested significantly in researching the properties of the water and developing dermatological applications derived from it.

This historical foundation distinguishes Avène from brands that adopt a “thermal water” narrative purely for marketing purposes. For Avène, the thermal spring and its medical-hydrotherapy heritage were established before the creation of the modern skincare line.

The contemporary Eau Thermale Avène brand was launched in 1990 by Laboratoires Pierre Fabre. By this time, Pierre Fabre had already established substantial expertise in the field. The group entered medical dermatology in 1982, while its broader dermo-cosmetics activities had commenced earlier. Consequently, Avène emerged from an existing ecosystem linking pharmacy, dermatology, scientific research, dermo-cosmetics, and thermal medicine, rather than as a standalone startup.

Avène is part of Laboratoires Pierre Fabre, a French healthcare company founded in 1962 by pharmacist and botanist Pierre Fabre. The founder’s philosophy focused on operating at the intersection of health and beauty, leading to a corporate structure that spans pharmaceuticals, medical dermatology, and dermo-cosmetics. Today, Pierre Fabre’s dermo-cosmetic portfolio includes other notable brands such as Ducray, A-Derma, Klorane, and René Furterer.

The parent company reported €3.2 billion in revenue in 2025, with a significant portion generated through international sales across roughly 130 territories. Thus, Avène serves as a flagship brand within a larger French healthcare and dermo-cosmetics group.

The core element of Avène’s identity is its Thermal Spring Water, used extensively across formulations and famously sold as a standalone aerosol spray. A specialized Water Laboratory is situated near the source in Avène.2

Research efforts have extended beyond mineral composition analysis to include microbiological characteristics, leading to the derivation of active ingredients from the spring’s unique microflora. For instance, Aquaphilus dolomiae served as the basis for active ingredients in the XeraCalm range, while I-modulia is described as a postbiotic active derived from thermal spring water research. This creates a brand architecture where thermal water leads to scientific research, which yields dermatological actives, ultimately forming the basis of skincare products.

Avène belongs to the French dermo-cosmetics tradition, a segment occupying the middle ground between ordinary cosmetics and pharmaceuticals. While designed for cosmetic use, these products are developed with a strong emphasis on:

• Dermatological science
• Skin physiology
• Tolerability
• Clinical evaluation
• Pharmacy distribution
• Collaboration with healthcare professionals

Pierre Fabre states that its research integrates dermatology and cosmetic science, involving hundreds of experts and evaluation studies annually. This approach explains why Avène’s packaging and communications prioritize skin tolerance, clinical testing, and specific skin conditions over purely aesthetic claims.

Since its launch in 1990, Avène’s portfolio has expanded to include approximately 180 dermo-cosmetic products.3 Key categories include:

Thermal Spring Water

Marketed as a flagship product, the aerosol spray is positioned for sensitive skin, focusing on soothing sensations and relieving discomfort.

Cicalfate+

This franchise focuses on skin repair, designed for skin that is irritated, damaged, or uncomfortable. It is one of the brand’s internationally recognized lines.

XeraCalm

Targeting very dry, itchy, and atopy-prone skin, the XeraCalm A.D. range combines Avène Thermal Spring Water with barrier-supporting ingredients. Formulations include I-modulia and lipid-based components like Cer-omega.3

Cleanance

Focused on acne and blemishes, the Cleanance line addresses oily and acne-prone skin with cleansers, treatments, and intensive care products. Pierre Fabre identifies acne as a primary area of expertise.

Sun Protection

Avène maintains a substantial photoprotection business, including high-SPF facial, body, and family products. Research led to the development of TriAsorB, a sunscreen filter introduced in 2020 after two decades of study, providing protection against UVB, UVA, and part of the high-energy visible-light spectrum.

Anti-Aging and Redness

The brand offers products targeting wrinkles, firmness loss, pigmentation, and redness, competing in premium skincare segments while retaining its dermatological positioning.

Pierre Fabre currently outlines five major areas of Avène expertise:

1. Skin repair (principally Cicalfate+)
2. Photoprotection (sun-care)
3. Acne (Cleanance)
4. Atopy-prone dry skin (XeraCalm)
5. Skin aging (anti-aging care)

These pillars illustrate that Avène is no longer solely a “thermal water brand.” Instead, thermal water acts as the heritage and scientific platform supporting a broad commercial portfolio addressing diverse dermatological needs.

A key competitive advantage for Avène is its relationship with the medical community. The company collaborates with dermatologists and scientists globally on product development, clinical protocols, studies, and professional recommendations. Additionally, the brand utilizes the Avène Hydrotherapy Center, a medical facility associated with dermatological thermal treatment.

Avène’s credibility strategy relies on medical expertise, thermal heritage, research, and tolerability, distinguishing it from brands that depend heavily on celebrity endorsement or luxury branding.

While originating as a French pharmacy brand, Avène has become an international business. Early expansion included Japan, where Pierre Fabre established a joint venture with Shiseido in 1986. The brand subsequently entered other Asian markets, launching in China in 2003. By 2023, Avène products were available in 115 international markets, generating 77% of the brand’s revenue from outside France.4

Avène’s growth has been significant. In 2023, approximately 130 million units were sold, supported by around 80,000 international prescribers. That year, the brand exceeded €1 billion in annual revenue, becoming the first Pierre Fabre brand to do so. By 2025, reported revenue reached approximately €1.2 billion.4

Avène’s identity is summarized by four concepts: French (thermal and pharmaceutical heritage), Dermatological (informed by medical science), Sensitive-skin focused, and Thermal (rooted in the spring). The resulting image contrasts with luxury beauty brands, communicating “dermatological care” rather than “luxury beauty.”

Conceptually, the philosophy follows the path: Nature → Science → Dermatology → Skin tolerance. Nature comes from the spring; science from Pierre Fabre’s infrastructure; dermatology from medical heritage; and tolerance bridges these elements for consumers with sensitive skin.

Innovation extends beyond the water itself. Notable technologies include:

• I-modulia®: A postbiotic active derived from thermal water research, used in XeraCalm to reduce itching and irritation.
• Aquaphilus dolomiae: A microorganism from the spring used as a basis for active ingredients.
• TriAsorB™: A broad-spectrum sunscreen technology introduced in 2020.
• Sterile Cosmetics®: A formulation and packaging approach used in ranges like XeraCalm to maintain sterility without conventional preservatives.

These innovations highlight how Avène’s thermal water serves as a platform for proprietary dermatological technologies.

Avène is strongly associated with French manufacturing. Pierre Fabre reported in 2022 that 95% of its industrial production occurred in France, although the global footprint has evolved. This origin contributes to brand equity, particularly in markets valuing French pharmacy skincare.

Regarding sustainability, the brand emphasizes protecting biodiversity and natural resources, given that its primary raw material is a natural spring. The thermal spring functions simultaneously as a natural resource, a scientific subject, a brand symbol, and a commercial asset.

Avène competes in the dermo-cosmetic / pharmacy skincare segment. Its closest competitors include brands such as La Roche-Posay, Vichy, Bioderma, Eucerin, CeraVe, Uriage, and SVR. Avène’s differentiation lies in its combination of thermal-water heritage, French pharmacy positioning, dermatological research, and sensitive-skin expertise.

Several factors contribute to Avène’s market position:

1. Clear Hero Ingredient: Thermal Spring Water provides immediate brand recognition.
2. Problem-Solution Orientation: Focuses on specific concerns like irritation, dryness, and acne.
3. Pharmacy Credibility: Operates within a medical/dermatological ecosystem.
4. French Heritage: Leverages the reputation of French pharmacy skincare.
5. Scientific Reinvestment: Continuous R&D transforms heritage into new technologies.
6. Broad Portfolio: Offers a complete routine from cleansing to anti-aging.

As of 2026, Avène has evolved from a thermal-water concept into a global dermatological skincare brand. Pierre Fabre describes a strategic shift toward “skin medicine,” emphasizing the brand’s role in addressing skin conditions alongside dermatological consultations. Despite this medical focus, Avène remains accessible as consumer skincare rather than prescription medication.

Eau Thermale Avène is a French dermo-cosmetic brand owned by Laboratoires Pierre Fabre, formally launched in 1990 but built upon the dermatological heritage of the Avène-les-Bains thermal spring acquired in 1975.1 Its signature ingredient, Avène Thermal Spring Water, serves as both a brand symbol and a foundation for scientific research.2 Originally focused on sensitive skin and thermal products, Avène has expanded into skin repair, acne, atopy-prone dryness, photoprotection, and anti-aging.3 With approximately €1.2 billion in revenue in 2025 and a presence in over 100 markets, Avène has grown from a niche French concept into a major global player in dermatological skincare.4

1. Eau Thermale Avène: €1 Billion in Revenue and a Strengthened Medical Position
2. XeraCalm A.D Lipid-replenishing balm | Eau Thermale Avène
3. Pierre Fabre Doubles Avène Plant Production Capacity with €50M Investment| Laboratoires Pierre Fabre
4. Eau Thermale Avène – Choose your country